Key result
Five interferon preparations protect HeLa cells against HSV-1 infection at low viral multiplicities.
Why the study?
The antiviral activity of different human interferon preparations against DNA and RNA viruses was compared to understand their protective effects.
Various human interferon preparations, including cloned α2 interferon, demonstrate protective antiviral activity against HSV-1 and several RNA viruses in vitro.
Answers are grounded in this paper and cite their sources.
In vitro data support interferon activity vs HSV-1; leaves open clinical translation and efficacy.
Five different interferon preparations were compared for their antiviral activity against Herpes simplex virus type 1 (HSV-1) and several RNA viruses. The interferons used were: interferon α from human buffy coats, interferon β from human fibroblasts, interferon γ from human lymphocytes after stimulation with phytohemagglutinin (PHA), lymphoblastoid interferon from Namalva cells IFN-α (Ly) and cloned α2 interferon produced by Escherichia coli containing the human gene for interferon α2. All preparations were able to protect monolayers of HeLa cells against HSV-1 infection when low multiplicities were used. The five IFN preparations were also tested against encephalomyocarditis (EMC) virus, poliovirus and vesicular stomatitis virus (VSV).
No takes yet. Share an insight, caveat, or question.
Muñoz et al. (1984) studied Viral infection (Herpes simplex virus type 1 and RNA viruses). Five different interferon preparations (α, β, γ, lymphoblastoid, cloned α2) was evaluated on Antiviral activity / protection of cell monolayers. Five different interferon preparations (α, β, γ, lymphoblastoid, and cloned α2) were all able to protect monolayers of HeLa cells against HSV-1 infection when low multiplicities were used.
Synapse has enriched 10 related papers. Consider them for comparative context: